Observational Familial Adenomatous Polyposis Registry Study In Patients Receiving Celecoxib Compared to Control Patients
Status:
Terminated
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This is a registry-based observational study assessing clinical outcomes in FAP patients
receiving celecoxib compared with historical/concurrent registry patients who have not
received celecoxib.
Both retrospective and prospective data will be utilized. No sampling methods apply.